Cough Management in Adults Without Red-Flag Symptoms
For an adult patient with cough and no red-flag symptoms, classify the cough by duration first: if less than 3 weeks (acute), reassure and provide symptomatic treatment only; if 3-8 weeks (subacute), consider postinfectious cough and trial inhaled ipratropium; if greater than 8 weeks (chronic), obtain chest X-ray and spirometry, then systematically treat for upper airway cough syndrome (UACS), asthma, and gastroesophageal reflux disease (GERD) in sequence. 1, 2
Initial Assessment: Duration-Based Classification
The first critical step is determining cough duration, as this narrows the differential diagnosis substantially 2:
- Acute cough: <3 weeks duration
- Subacute cough: 3-8 weeks duration
- Chronic cough: >8 weeks duration
Red Flags to Exclude Immediately
Before proceeding with routine management, screen for these warning signs that require urgent evaluation 2:
- Hemoptysis
- Smoker >45 years with new or changed cough
- Adults 55-80 years with 30 pack-year smoking history
- Prominent dyspnea (especially at rest/night)
- Hoarseness
- Fever, weight loss, or peripheral edema
- Trouble swallowing
- Recurrent pneumonia
Acute Cough (<3 Weeks)
Most acute coughs are viral upper respiratory tract infections—benign and self-limiting 1.
Management Approach:
- No antibiotics needed (even with colored sputum—this is viral) 3
- Symptomatic treatment only: Honey and lemon, dextromethorphan-containing cough remedies, paracetamol, menthol lozenges 1, 3
- Do NOT prescribe: Expectorants, mucolytics, antihistamines, or bronchodilators 3
- Smoking cessation if applicable 1
When to Investigate Acute Cough:
Consider chest X-ray if patient has 3, 4:
- New focal chest signs
- Dyspnea or tachypnea
- Fever >4 days
- C-reactive protein >30 mg/L (strengthens pneumonia diagnosis) 4
Common Pitfall: Prescribing antibiotics for colored sputum. Purulent sputum in acute cough is typically viral inflammation, not bacterial infection.
Subacute Cough (3-8 Weeks)
This is typically postinfectious cough following viral respiratory infection 5.
Pathophysiology:
Multiple factors contribute: postviral airway inflammation, bronchial hyperresponsiveness, mucus hypersecretion, impaired mucociliary clearance 5.
Treatment Algorithm:
- First-line: Trial of inhaled ipratropium (may attenuate cough) 5
- Second-line: Inhaled corticosteroids if cough adversely affects quality of life and ipratropium fails 5
- For severe paroxysms: Consider prednisone 30-40 mg daily for short course (after ruling out UACS, asthma, GERD) 5
- Last resort: Central antitussives (codeine or dextromethorphan) 5
Important: If cough persists >8 weeks, reclassify as chronic cough and proceed with chronic cough evaluation 5, 1.
Special Consideration - Pertussis:
If cough ≥2 weeks with paroxysms, post-tussive vomiting, or inspiratory whoop, suspect Bordetella pertussis and obtain nasopharyngeal culture/PCR 5.
Chronic Cough (>8 Weeks)
Mandatory baseline investigations 1:
- Chest X-ray
- Spirometry
- Quantify cough severity using validated tool
Systematic Treatment Algorithm
The evidence supports a sequential empiric approach targeting the three most common causes 6, 2:
Step 1: Upper Airway Cough Syndrome (UACS)
Treat first for rhinosinus conditions 6:
- First-generation antihistamine/decongestant combination
- Intranasal corticosteroids
- Assess response in 2-4 weeks
Step 2: Asthma/Cough-Variant Asthma
If UACS treatment fails 6:
- Trial inhaled β-agonists
- Add inhaled corticosteroids
- Consider leukotriene inhibitors
- If above fail, trial oral corticosteroids for definitive response assessment
Step 3: Nonasthmatic Eosinophilic Bronchitis (NAEB)
Before extensive GERD workup 6:
- Induced sputum for eosinophil count (should be available after excluding common causes) 1
- If eosinophilia present, treat with inhaled corticosteroids
- Response is highly predictable
Step 4: Gastroesophageal Reflux Disease (GERD)
For patients with 6:
- Cough >2 months
- Normal chest X-ray
- Non-smoker
- Not on ACE inhibitors
- Failed UACS/asthma/NAEB treatment
Treatment regimen:
- Proton pump inhibitor (PPI) for minimum 2 months (intensive acid suppression) 1
- Antireflux diet and lifestyle modifications
- Add prokinetic agent (metoclopramide) if inadequate response 6
- Response time variable: 2 weeks to several months 6
Critical Point: Acid suppression alone is no longer recommended—must include lifestyle modifications 2.
Additional Considerations
ACE Inhibitor-Induced Cough:
- Discontinue ACE inhibitor (or sitagliptin) if patient is taking one 5, 2
- Cough may take weeks to resolve after discontinuation
Environmental/Occupational Exposures:
- Specifically inquire about workplace exposures, irritants, allergens 2
Follow-up:
- Reassess within 4-6 weeks after initial evaluation 2
- Quantify treatment effects formally using validated tools 1
Refractory or Unexplained Chronic Cough
If cough persists despite systematic treatment of common causes 5, 2:
Further Evaluation:
- Chest CT scan (not just X-ray) 5
- Bronchoscopy if indicated 5
- Rule out uncommon causes before labeling as unexplained 5
Management Options:
- Referral to specialized cough clinic 2
- Speech/physiotherapy for cough hypersensitivity syndrome 7, 8, 9
- Pharmacologic neuromodulators (off-label):
Emerging therapies: P2X3 receptor antagonists (gefapixant, cafiglumab) are under investigation for refractory chronic cough 7, 8.
Key Clinical Pitfalls
Ordering extensive testing prematurely: History, exam, chest X-ray, and spirometry are sufficient initially for chronic cough without red flags 8, 10
Not quantifying cough severity: Use validated instruments (Leicester Cough Questionnaire, Cough Severity Diary) to assess baseline and treatment response 1, 2
Inadequate treatment trials: Each empiric treatment requires adequate duration (typically 4-6 weeks) and optimization before declaring failure 8, 10
Missing multiple simultaneous causes: Chronic cough frequently has overlapping etiologies—treat sequentially but recognize combinations occur 5, 2
Premature diagnosis of "unexplained cough": This is a diagnosis of exclusion only after thorough evaluation and treatment trials 5, 10